Dark

BTX
BlackRock Technology and Private Equity Term Trust
stock NYSE

At Close

Feb 6, 2026 3:59:30 PM EST

6.54USD+4.140%(+0.26)1,303,480

0.00Bid 0.00Ask 0.00Spread

Pre-market

Feb 4, 2026 9:04:30 AM EST

6.47USD+3.025%(+0.19)0

After-hours

Feb 4, 2026 4:38:30 PM EST

6.39USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

763.29M

Headquarters

CA, USA

Industry

Biotechnology

Last Dividend

Mar 14, 20250.086

Last Split

Oct 17, 20221for20reverse

GERN MNTA PDLI OMER BAX SNY TEVA TECH GENE XLV

BTX Stats

Avg. Vol. 10 Day

972,676

Avg. Vol. 30 Day

1,005,279

Employees

Market Cap

763,285,349

Shares Out.

116,710,298

On/Off Exchange

49%/51%

6 Month Beta

1.41

1 Year Beta

1.15

3 Year Beta

1.03

52 Week Low

5.10

52 Week High

8.12

SMA50

6.70

SMA200

6.89

1 Week

-2.10%

1 Month

-3.97%

3 Month

-6.71%

6 Month

-11.86%

1 Year

-16.79%

5 Year

-96.26%

Profile

Brooklyn is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. The company is also exploring opportunities to advance therapies using leading edge gene editing/cell therapy technology through its option agreements with Factor Bioscience and Novellus. Brooklyn's most advanced program is studying the safety and efficacy of IRX-2 in patients with head and neck cancer. In a Phase 2A clinical trial in head and neck cancer, IRX-2 demonstrated an overall survival benefit. Additional studies are either underway or planned in other solid tumor cancer indications.

BTX Stock Summary

BlackRock Technology and Private Equity Term Trust (NYSE:BTX) stock price today is $6.54, and today's volume is 1,303,480. BTX is up 4.140% today. The 30 day average volume is 1,005,279. BTX market cap is 763.29M with 116,710,298 shares outstanding.